Retention in a public healthcare system with free access to treatment: a Danish nationwide HIV cohort study

被引:45
作者
Helleberg, Marie [1 ,6 ]
Engsig, Frederik N. [1 ]
Kronborg, Gitte [2 ]
Larsen, Carsten S. [3 ]
Pedersen, Gitte [4 ]
Pedersen, Court [5 ]
Gerstoft, Jan [1 ]
Obel, Niels [1 ]
机构
[1] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen O, Denmark
[2] Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2650 Hvidovre, Denmark
[3] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark
[4] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark
[5] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark
[6] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark
关键词
continuity of patient care; HIV; lost to follow-up; mortality; retention; ACTIVE ANTIRETROVIRAL THERAPY; FOLLOW-UP; INFECTED PATIENTS; DRUG-RESISTANCE; DENMARK; RISK; INTERRUPTION; INDIVIDUALS; ENGAGEMENT; MORTALITY;
D O I
10.1097/QAD.0b013e32834fa15e
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: We aimed to assess retention of HIV-infected individuals in the Danish healthcare system over a 15-year period. Methods: Loss to follow-up (LTFU) was defined as 365 days without contact to the HIV care system. Data were obtained from the nationwide Danish HIV Cohort study, The Danish National Hospital Registry and The Danish Civil Registration System. Incidence rates, risk factors for LTFU and return to care and mortality rate ratios (MRRs) were estimated using Poisson regression analyses. Results: We included 4745 HIV patients who were followed for 36 692 person-years. Patients were retained in care 95.0% of person-years under observation, increasing to 98.1% after initiation of highly active antiretroviral treatment (HAART). The overall incidence rate/100 person-years for first episode of LTFU was 2.6 [95% confidence interval (CI) 2.5-2.8] and was significantly lower after initiation of HAART [1.2 (95% CI 1.0-1.3)]. Five years after LTFU the probability of return to care was 0.87 (95% CI 0.84-0.90). The risk of death was significantly increased after LTFU [MRR 1.9 (95% CI 1.6-2.6)] and 6 months or less after return to care [MRR 10.9 (95% CI 5.9-19.9)]. Conclusion: Retention in care of Danish HIV patients is high, especially after initiation of HAART. Absence from HIV care is associated with increased mortality. We conclude that high rates of retention can be achieved in a healthcare system with free access to treatment and is associated with a favorable outcome. (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:741 / 748
页数:8
相关论文
共 30 条
  • [1] Arici Claudio, 2002, HIV Clin Trials, V3, P52
  • [2] Molecular Phylogenetics of Transmitted Drug Resistance in Newly Diagnosed HIV Type 1 Individuals in Denmark, a Nation-Wide Study
    Audelin, Anne Margrethe
    Gerstoft, Jan
    Obel, Niels
    Mathiesen, Lars
    Laursen, Alex
    Pedersen, Court
    Nielsen, Henrik
    Jensen, Janne
    Nielsen, Lars
    Nielsen, Claus
    Jorgensen, Louise Bruun
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (12) : 1284 - 1291
  • [3] The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005
    Audelin, Anne Margrethe
    Lohse, Nicolai
    Obel, Niels
    Gerstoft, Jan
    Jorgensen, Louise Bruun
    [J]. ANTIVIRAL THERAPY, 2009, 14 (07) : 995 - 1000
  • [4] Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1
  • [5] Comparisons of causes of death and mortality rates among HIV-infected persons - Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras
    Crum, NF
    Riffenburgh, RH
    Wegner, S
    Agan, BK
    Tasker, SA
    Spooner, KM
    Armstrong, AW
    Fraser, S
    Wallace, MR
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (02) : 194 - 200
  • [6] Emergence of HIV-1 mutated strains after interruption of highly active antiretroviral therapy in chronically infected patients
    Daniel, N
    Schneider, V
    Pialoux, G
    Krivine, A
    Grabar, S
    Nguyen, TH
    Girard, PM
    Rozenbaum, W
    Salmon, D
    [J]. AIDS, 2003, 17 (14) : 2126 - 2129
  • [7] El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360
  • [8] The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
    Gardner, Edward M.
    McLees, Margaret P.
    Steiner, John F.
    del Rio, Carlos
    Burman, William J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (06) : 793 - 800
  • [9] High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort
    Gerver, Sarah M.
    Chadborn, Tim R.
    Ibrahim, Fowzia
    Vatsa, Bela
    Delpech, Valerie C.
    Easterbrook, Philippa J.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2010, 13
  • [10] Causes of Death in HIV-1-Infected Patients Treated with Antiretroviral Therapy, 1996-2006: Collaborative Analysis of 13 HIV Cohort Studies
    Gill, John
    May, Margaret
    Lewden, Charlotte
    Saag, Mike
    Mugavero, Michael
    Reiss, Peter
    Ledergerber, Bruno
    Mocroft, Amanda
    Harris, Ross
    Fux, Christoph A.
    Justice, Amy
    Costagliola, Dominique
    Casabona, Jordi
    Hogg, Robert S.
    Khaykin, Pavel
    Lampe, Fiona
    Vehreschild, Janne
    Sterne, Jonathan A. C.
    Egger, Matthias
    Brodt, Hans-Reinhard
    Casabona, Jordi
    Chene, Genevieve
    Costagliola, Dominique
    Dabis, Francois
    Monforte, Antonella D'Arminio
    de Wolf, Frank
    Faetkenheuer, Gerd
    Gill, John
    Guest, Jodie
    Hogg, Robert S.
    Justice, Amy
    Kirk, Ole
    Kitahata, Mari
    Lampe, Fiona
    Ledergerber, Bruno
    Reiss, Peter
    Sterling, Tim
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (10) : 1387 - 1396